Study of prevalence pattern of neoplastic intracranial tumor in the tribal area of Rajasthan, India


  • Cheeni Jain Department of Pathology, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India
  • Vivek Kumar Jain Department of Pathology, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India
  • N. Mogra Department of Pathology, Geetanjali Medical College and Hospital, Udaipur, Rajasthan, India



Astrocytoma, Meningioma, Prevalence, WHO grading


Background: Prevalence estimates available for brain tumors reflect the portion of tumors that are malignant. Just as routine incidence statistics from cancer registries under represent the full spectrum of primary brain tumor cases. Prevalence rates are ideally suited to provide an overall estimate of cancer survivorship and direction for health planning.

Methods: A total of 70 cases of CNS tumors were retrieved from the archives of the Department of Pathology, Geetanjali Medical College & hospital, Udaipur from April 2014 to September 2016. The diagnoses in all the cases were made on histological examination of processed tissue.

Results: In our study astrocytoma was the most common brain tumor (34.28%), followed by meningioma (32.85%). The third common tumor was oligodendroglioma (11. 42%). However, metastatic brain tumors were seen in only 5.55 % of cases in the present study.

Conclusions: Males were at higher risk of developing CNS lesions in comparison to females. WHO Grade I lesions were more common in our institutional set up. Astrocytoma WHO grade IV lesions were more common in comparison to Grade I lesions, indicating need for imaging and neurology consultation at primary grass root level.


Adami HO, Gunnarsson T, Sparen P, Eklund G. The prevalence of cancer in Sweden. Acta Oncol. 1984;28:463-70.

Kumar A, Robbins F. Cotran pathologic basis of disease. Ninth Edition. 9th edition. 2016:1306.

Davis FG, Mccarthy B, Jukich P. The descriptive epidemiology of brain tumors. Neuroimaging Clin. N Am. 1999;9:581-94.

Hakama M, Hakulinen T, Teppo L, Saxena E. Incidence, mortality or prevalence as indicators of the cancer problem. Cancer. 1975;36:2227-31.

Merrill RM, Capocaccia R, Feuer EJ, Mariotto A. Cancer prevalence estimates based on tumor registry data in the surveillance, epidemiology, and end results (SEER) program. Int J Epid. 2000;29:197-207.

Aryal G. Histopathological pattern of central nervous system tumor: a three year retrospective study. J Pathology Nepal. 2011;1:22-5.

Surawicz TS, Mccarthy BJ, Kupelian V, Jukich PJ, Bruner JM, Davis FG. Descriptive epidemiology of primary brain and CNS tumors: results from the central brain tumor registry of the United States 1990-1994. Neuro Oncol. 1999;1:14-25.

Lee CH, Jung KW, Yoo H, Park S, Lee SH. Epidemiology of primary brain and central nervous system tumors in Korea. J Korean Neurosurg Soc. 2010;48:145-52.

Feldman AR, Kessle L, Myers MH, Naughton MD. The prevalence of cancer: estimates based on the connecticut tumor registry. N Engl J Med. 1986;315:1394-7.

Davis FG, Kupelian V, Freels S, Mccarthy B, Surawicz T. Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups. Neuro Oncol. 2001;3:152-8.

Louis DN, Ohgaki H, Wiestler OD. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109.






Original Research Articles